These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16350933)

  • 1. Gender-specific aspects of cardiovascular disease.
    Roberts BH
    Med Health R I; 2005 Oct; 88(10):339-41. PubMed ID: 16350933
    [No Abstract]   [Full Text] [Related]  

  • 2. Are statin effects mediated through, or in spite of, their cholesterol-lowering action?
    Mascitelli L; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(2):262-3. PubMed ID: 19141486
    [No Abstract]   [Full Text] [Related]  

  • 3. Study stirs debate about statin use in those without high cholesterol.
    Mayo Clin Womens Healthsource; 2009 Apr; 13(4):3. PubMed ID: 19255535
    [No Abstract]   [Full Text] [Related]  

  • 4. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
    Olsson AG
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
    [No Abstract]   [Full Text] [Related]  

  • 5. Statins and all-cause mortality in high-risk primary prevention of patients with cardiovascular risk factors.
    Brugts JJ; Deckers JW
    Arch Intern Med; 2010 Dec; 170(22):2041; author reply 2043-4. PubMed ID: 21149768
    [No Abstract]   [Full Text] [Related]  

  • 6. JUPITER study highlights C-reactive protein as a cardiac risk factor.
    Cardiovasc J Afr; 2009; 20(2):146. PubMed ID: 19421655
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of statins in primary prevention.
    Savill P
    Practitioner; 2009; 253(1720):7. PubMed ID: 19715050
    [No Abstract]   [Full Text] [Related]  

  • 8. [JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects].
    Håkansson J
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1460-1. PubMed ID: 19579433
    [No Abstract]   [Full Text] [Related]  

  • 9. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
    Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
    Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
    [No Abstract]   [Full Text] [Related]  

  • 10. Trial evidence for statin-based primary prevention remains dubious.
    Muldoon MF
    J Am Coll Cardiol; 2009 Jun; 53(24):2312; author reply 2312-3. PubMed ID: 19520264
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins in primary prevention: uncertainty in women, elderly.
    Allen M;
    Am Fam Physician; 2006 Mar; 73(6):973-4; author reply 974. PubMed ID: 16570733
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins reduce cardiovascular events in primary and secondary prevention trials without causing an increase in carcinoma.
    Aronow WS
    J Am Geriatr Soc; 2009 Oct; 57(10):1942-3; author reply 1943-4. PubMed ID: 19807799
    [No Abstract]   [Full Text] [Related]  

  • 13. Lowering cholesterol: is there a limit?
    Harv Mens Health Watch; 2007 May; 11(10):5-6, 8. PubMed ID: 17514824
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most would fail to benefit from JUPITER Intervention.
    Plonk WM
    J Am Coll Cardiol; 2009 Aug; 54(8):744; author reply 744-5. PubMed ID: 19679258
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular form and function: two mechanisms for cardiovascular prevention.
    Kinlay S
    Eur Heart J; 2008 Jul; 29(14):1711-3. PubMed ID: 18539586
    [No Abstract]   [Full Text] [Related]  

  • 18. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.
    Robson J
    Heart; 2008 Oct; 94(10):1331-2. PubMed ID: 18701534
    [No Abstract]   [Full Text] [Related]  

  • 20. Can statins help healthy people?
    Johns Hopkins Med Lett Health After 50; 2009 Mar; 21(1):1. PubMed ID: 19370796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.